RECRUITING

Bladder Cancer Screening Trial

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

There is currently no accepted screening strategy for patients at high risk of developing bladder cancer. This study will ask patients to complete a urine test every 6 months for 2 years to help assess if routine screening helps finding bladder cancer at an earlier stage.

Official Title

Optimal Screening Strategy for Bladder Cancer in at Risk Patients

Quick Facts

Study Start:2023-05-05
Study Completion:2028-04
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05646485

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:50 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age ≥ 50
  2. * Smoking: ≥15 pack-year smoking history
  3. * Occupation:≥ 15 years of occupational exposures including: textile worker, painter, dry cleaners
  1. * Prior history of bladder, kidney, or prostate cancer
  2. * Prior evaluation of micro or gross hematuria within the last 2 years
  3. * Do not provide informed consent

Contacts and Locations

Study Contact

Yair Lotan, MD
CONTACT
214-648-0389
yair.lotan@UTsouthwestern.edu

Principal Investigator

Yair Lotan, MD
PRINCIPAL_INVESTIGATOR
UT Southwestern Medical Center

Study Locations (Sites)

University of Texas Southwestern Medical Center
Dallas, Texas, 75390
United States

Collaborators and Investigators

Sponsor: University of Texas Southwestern Medical Center

  • Yair Lotan, MD, PRINCIPAL_INVESTIGATOR, UT Southwestern Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-05-05
Study Completion Date2028-04

Study Record Updates

Study Start Date2023-05-05
Study Completion Date2028-04

Terms related to this study

Additional Relevant MeSH Terms

  • Bladder Cancer
  • Urothelial Carcinoma
  • Hematuria
  • Smoking Cessation